Nanobody-based chimeric antigen receptor T cells designed by CRISPR/Cas9 technology for solid tumor immunotherapy
利用CRISPR/Cas9技术设计基于纳米抗体的嵌合抗原受体T细胞用于实体肿瘤免疫治疗
期刊:Signal Transduction and Targeted Therapy
影响因子:40.8
doi:10.1038/s41392-021-00462-1
Fengzhen Mo, Siliang Duan, Xiaobing Jiang, Xiaomei Yang, Xiaoqiong Hou, Wei Shi, Cueva Jumbo Juan Carlos, Aiqun Liu, Shihua Yin, Wu Wang, Hua Yao, Zihang Yu, Zhuoran Tang, Shenxia Xie, Ziqiang Ding, Xinyue Zhao, Bruce D Hammock, Xiaoling Lu